Literature DB >> 598395

Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor.

R J Ablin, R A Bhatti, G R Bruns, P D Guinan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 598395     DOI： 10.1016/0014-2964(77)90056-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.

Authors:  R A Bhatti; R J Ablin; P D Guinan; E Totonchi; S Zamora
Journal:  Experientia       Date:  1978-10-15

2.  Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.

Authors:  R J Ablin; R A Bhatti; P D Guinan; W Khin
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

3.  Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.

Authors:  S Müller; T M Ernst
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

4.  Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary report.

Authors:  R J Ablin; R A Bhatti; P D Guinan; I M Bush
Journal:  Experientia       Date:  1979-11-15

5.  Trial of specific antigen-mediated leukocyte adherence inhibition test in patients with chronic active hepatitis and hepatitis B carrier.

Authors:  Y I Oh; S H Song; W H Kim; K H Cho; J K An; D S Ahn
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.